The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.
The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.
The Department of Health and Human Services (HHS) issued a statement on Sunday:
The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.
NEA insider blows whistle on ‘toxic’ culture and far-left politics inside teachers union: ‘It’s a cult’
Trump Forces the Fake News to Stare at the Mugshots of Violent Illegal Criminals Caught By ICE
GOP Barely Passes DHS, ICE Funding Thanks to 7 Democrats Who Defied Their Party
Doubts abound about proposed dual citizenship ban
Maine’s bipartisan brand of political nepotism
Texas hold ’em: Greg Abbott argues he set the standard for governors and illegal immigration
Nevada judge retires after court grants protective order to attorney she was accused of stalking
Trump says US should have tested NATO by invoking Article 5 over border security
Top 5 moments from Jack Smith’s testimony on Capitol Hill
Trump snubs Canada by withdrawing country’s invite to join ‘most prestigious Board of Leaders ever’
Newly minted Virginia AG who fantasized about opponent’s family dying roasted over glaring typo
Video captures Detroit student allegedly wielding box cutter in classroom chase as teacher intervenes
RNC eyes ‘America First’ midterm convention to boost Trump, GOP ahead of critical elections
Inside ‘MELANIA’: The unprecedented access behind Melania Trump’s first film
Armed carjacker’s wild Corvette rampage turns downtown into war zone; sergeant wounded in deadly shootout
HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”
Earlier, the French government had approved similar drugs to treat the virus.
Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”
NEA insider blows whistle on ‘toxic’ culture and far-left politics inside teachers union: ‘It’s a cult’
Trump Forces the Fake News to Stare at the Mugshots of Violent Illegal Criminals Caught By ICE
GOP Barely Passes DHS, ICE Funding Thanks to 7 Democrats Who Defied Their Party
Doubts abound about proposed dual citizenship ban
Maine’s bipartisan brand of political nepotism
Texas hold ’em: Greg Abbott argues he set the standard for governors and illegal immigration
Nevada judge retires after court grants protective order to attorney she was accused of stalking
Trump says US should have tested NATO by invoking Article 5 over border security
Top 5 moments from Jack Smith’s testimony on Capitol Hill
Trump snubs Canada by withdrawing country’s invite to join ‘most prestigious Board of Leaders ever’
Newly minted Virginia AG who fantasized about opponent’s family dying roasted over glaring typo
Video captures Detroit student allegedly wielding box cutter in classroom chase as teacher intervenes
RNC eyes ‘America First’ midterm convention to boost Trump, GOP ahead of critical elections
Inside ‘MELANIA’: The unprecedented access behind Melania Trump’s first film
Armed carjacker’s wild Corvette rampage turns downtown into war zone; sergeant wounded in deadly shootout
President Donald Trump has suggested that hydroxychloroquine could be effective, and has encouraged further study. His interest in the drug has prompted pushback from the media.
NBC News’ Peter Alexander accused the president last week of giving Americans “false hope,” and Politico’s Dan Diamond reported Sunday that the FDA decision came despite “scant evidence,” adding that “[c]areer scientists have been skeptical of the effort.”
Story cited here.
